DOC Q3 FY26 earnings call: key takeaways

• The company raised guidance for the third consecutive quarter, citing strong leasing and operational performance. (6:30)

Results vs expectations

EPS basis: Adjusted EPS, provider (EODHD); matches the company press release

The stock moved +0.4% over the report window (S&P 500 ETF +0.3%). Earnings history

What changed since last quarter

• Guidance for FFO adjusted raised by two cents at the midpoint to $1.76–$1.78 per share. (10:30)
• Same store cash NOI guidance increased by 50 basis points to 0.5%–2.0%. (10:30)
• Life science acquisitions are seen as strategic and cheap, with 70% of acquired vacancy already under lease discussions. (12:46)

What analysts pressed on

• Whether the current pace of lab leasing will sustain through 2027. (18:07)
• How the company plans to manage debt maturities in 2027 with higher interest rates. (42:58)
• Concerns about the impact of asset redevelopments and sales on same store metrics. (39:58)

In their words

• We don't focus on same store because it ignores equally important items like capex and moving properties in and out of the pool. Scott Brinker (1:29)
• We've done a really great job of that over the last 15 or so months. (23:09)